Effective Dosing of Burosumab in XLH

Clinical trial NCT07183579 · RECRUITING

Trial details

NCT number: NCT07183579
Sponsor: University of Nottingham
Status: RECRUITING
Study type: OBSERVATIONAL

X-linked Hypophosphatemia (XLH)

Start date: 2025-11-03
Primary completion: 2026-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.